美股市场个股详情
CTMX CytomX
- 1.890
- -0.090-4.55%
收盘价 05/13 16:00 (美东)
- 1.910
- +0.020+1.06%
盘后 19:09 (美东)
1.47亿总市值9.00市盈率TTM
2.010最高价1.880最低价605.62万股成交量1.950今开1.980昨收1183.28万成交额11.16%换手率亏损市盈率(静)7791.94万总股本5.85052周最高-4.64市净率1.03亿流通值1.04052周最低--股息TTM5424.71万流通股35.000历史最高--股息率TTM6.57%振幅1.040历史最低1.953平均价1股每手
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
CytomX股票讨论区
CytomX Therapeutics, Inc. (Nasdaq: CTMX) unveiled positive initial data from its ongoing CX-904 Phase 1a dose escalation clinical study. This pivotal study is centered around CX-904, an investigational PROBODY® T-cell engager that is both masked and conditionally activated, designed to target t...
Striding towards revolutionizing cancer therapy, CytomX Therapeutics, Inc. (Nasdaq: CTMX) has announced a clinical trial collaboration and supply agreement with pharmaceutical giant Merck (known as MSD outside of the US and Canada). This collaboration is set to explore the therapeutic potential of CX-801, a novel, dually-m...
暂无评论